Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Phone Dekho Opens Second Outlet, Plans National Presence with 100 Stores in a Year Business
  • Bollywood’s new star Bhagyesh Hendre is rocking the music world Business
  • One of the Best Event Agency in Delhi NCR: How Effortless Events Is Raising the Bar for Professional Event Management Lifestyle
  • Ms. Tina Khandait Takes Best Emerging talent in indo western Award in National Designer Award 2023 Entertainment
  • GaiaQ Digital Marketing – Transforming the Digital Space Business
  • Vasu Healthcare Unveils its Largest Flagship Outlet in the heart of Vadodara City Health
  • GAP Group Hosts GICEA Delegation in Dholera SIR Business
  • Clutch Recognizes OpenTeQ Technologies among Arizona’s Top Software Developers for 2022 Business

Optimus Pharma granted permission for Restricted Use under Emergency Situation from the DCGI for its COVID-19 pill MOLNUPIRAVIR

Posted on December 28, 2021 By

Hyderabad (Telangana) [India], December 28: Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.  Optimus Pharma successfully completed the Phase 3 Clinical Trial on 1218 subjects across 29 geographical study sites all over India. “We want to cover maximum demographic diversity into our trial in order to obtain data across the different geographical regions of the country and conclusive evidence that Molnupiravir is able to bring about viral load reduction over 5 days of treatment duration,” said Chairman and Managing Director of Optimus Pharma, Dr D Srinivasa Reddy. Optimus Pharma has developed the API in the house at its R&D centre in Hyderabad. Optimus Pharma has revealed highly promising results of the drug in its ability to reduce viral load and bring out significant symptomatic improvement in patients’ health.

It is to be noted that in the Clinical Trial, Molnupiravir was administered to the subjects along with Standard of Care (SoC) medication as per the approved protocol by CDSCO. The trial was successful in establishing a clinical significant results of ‘Molnupiravir + SoC’ over ‘SoC’ arm.

  • Rate of hospitalization was less in Molnupiravir+SoC when compared to SoC group.
  • Greater clinical improvement observed in Molnupiravir + SoC arm compared to SOC alone by Day 5 and Day 10.
  • Proportion of subjects with RT-PCR negativity at Day 5 and Day 10 was statistically significant in Molnupiravir + SoC arm.
  • Higher viral load reduction was observed in Molnupiravir+ SoC arm
  • No serious safety concerns observed with Molnupiravir in overall study duration, no mortality was observed in the trial across both the arms

 Molnupiravir is administered as an 800 mg dose by orally consuming four capsules of 200mg twice a day. Upon oral administration, Molnupiravir, being a prodrug, is metabolized into its active form and converted into its triphosphate (TP) form. The TP form of Molnupiravir is incorporated into RNA and inhibits the action of viral RNA-dependent RNA polymerase. This results in the termination of RNA transcription, thereby significantly reducing viral replication.

Optimus Pharma is ready with a commercial quantity of the drug to cater to the unmet medical need of the nation. It is with heartfelt gratitude that we thank the Subject Expert Committee of the CDSCO and the DCGI for their valuable recommendations and guidance for the Clinical Trial, thereby making this project a huge success, said Dr D. Srinivas Reddy (MD Optimus) in his statement to the press. Optimus Pharma is committed to consistently integrating quality, affordability and reliability into their products and ensuring timely access to life-saving medication to whomsoever is in need.

Business Tags:Business

Post navigation

Previous Post: Candid chat with Mrs India Earth Poonam Chaubey
Next Post: Babubhai Sweets From Surat Sets World Record For Biggest Ghari 15 Kg and Smallest Ghari 15 Gm

Related Posts

  • World Kidney Day 2025: Understanding Kidney Health with Expert Advice on Prevention and Early Diagnosis Business
  • Airfloa Rail Technology Limited IPO Opens on Sept 11, 2025 Business
  • Cinelal Head Mrs Alankrit Rathod appoints new OTT team Business
  • Indian-Owned Phonato Studios’ Games Cross 10 Million Downloads Business
  • Infraprime Logistics Technologies Limited Received In-Principle Approval From BSE Business
  • Datuk (Dr) Vinod Sekhar felicitated at 22nd Asian Business and Social Forum with Bhartiya Mahantam Vikas Puraskar 2023-24 Business

Recent Posts

  • Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore
  • Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027
  • India’s DeepTech Capital Needs People Who Can Put It to Work
  • Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput
  • Bench Mark Infotech Services Limited Reports H1 FY27 Results

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Nidarshana Gowani Announces Two Grand Editions of ‘Hema Malini LIVE In Concert’ in Mumbai Nehru Centre and Delhi Lifestyle
  • What’s So Unique About Online MBA? Uncover How It Boosts Your Career Education
  • What Equity Investors Should Know About Using Loan Against Shares for Short-Term Liquidity Finance
  • Divadiya.com presents unique multi-purpose shoe rack and sneaker storage box Lifestyle
  • Mumbai’s Hottest DJ, Tejas Shetty, Rocks the City with High-Energy Sets Entertainment
  • Trademark battle for brick brand reaches court – Imitator stopped from using brand Business
  • Kashmik Formulation Sanand Plant celebrates Navratri with its employees on Garba Beats Lifestyle
  • Algo Trading Myth & Misconception Prevailing in The Market Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme